Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Toronto Stock Exchange  >  Cronos Group Inc.    CRON   CA22717L1013

CRONOS GROUP INC.

(CRON)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Toronto Stock Exchange
02/22/2021 02/23/2021 02/24/2021 02/25/2021 02/26/2021 Date
14.78(c) 14.03(c) 14.26(c) 13.58(c) 13.44 Last
835 493 1 533 203 1 162 885 682 571 1 177 555 Volume
-4.52% -5.07% +1.64% -4.77% -1.03% Change
More quotes
Financials
Sales 2020 54,2 M 42,7 M 42,7 M
Net income 2020 6,46 M 5,09 M 5,09 M
Net Debt 2020 - - -
P/E ratio 2020 672x
Yield 2020 -
Sales 2021 118 M 92,9 M 92,9 M
Net income 2021 -115 M -90,8 M -90,8 M
Net Debt 2021 - - -
P/E ratio 2021 -43,9x
Yield 2021 -
Capitalization 4 892 M 3 909 M 3 851 M
Capi. / Sales 2020 90,3x
Capi. / Sales 2021 41,4x
Nbr of Employees 631
Free-Float 50,8%
More Financials
Company
Cronos Group Inc is a cannabinoid company. The Company is focused on cannabis research, technology and product development. The Company’s portfolio includes PEACE NATURALS, COVE, Spinach, Lord Jones and PEACE+. PEACE NATURALS a global wellness platform. The COVE and Spinach are adult-use brands. The Lord Jones and PEACE+ are hemp-derived cannabidiol (CBD) brands. The Company’s segments include United States and... 
Sector
Pharmaceuticals
Calendar
02/26Earnings Release
More about the company
Notations Surperformance© of Cronos Group Inc.
Trading Rating : Investor Rating :
More Ratings
All news about CRONOS GROUP INC.
09:07aPIPER SANDLER ON CRONOS : Operating Losses Larger Than Expected in Q4 2020
MT
08:33aCRONOS : Swings to Q4 Loss, Revenue Higher
MT
08:23aCRONOS : Reports Q4 Consolidated Net Revs US$17 Million as Net Loss Widens to US..
MT
07:37aCRONOS BRIEF : Posts Adjusted EBITDA Loss of US$53.1 Million in Q4 2020, Up $1.5..
MT
07:35aCRONOS BRIEF : Says Preserved "Robust" Balance Sheet With Near US$1.3 Billion In..
MT
07:34aCRONOS BRIEF : Reports Q4 Consolidated Net Revs US$17.046 Million Vs Last Year ..
MT
07:34aCRONOS : Earnings Flash (CRON.TO) CRONOS GROUP Posts Q4 Revenue US$17.0 Million
MT
03:15aCellular Goods Starts London Trading After $18 Million IPO
MT
03:02aINCANNEX HEALTHCARE : Widens Net Loss in July-December 2020 on as R&D Spending S..
MT
02/25SUGARBUD CRAFT GROWERS : to Supply Craft Cannabis Collection to Ontario Retail C..
MT
02/25TILRAY : Indus Holdings buys Miley Cyrus-backed pot producer
RE
02/25Harvest One Cannabis Boosts Bought-Deal Share-Unit Offering to C$5 Million
MT
02/24Little Green Pharma Swings to Profit in Fiscal H1 as Medicinal Cannabis Sale,..
MT
02/24INNOVATIVE INDUSTRIAL PROPERTIES : Higher Q4 Results Short of Street Estimates
MT
02/24Harvest One Cannabis Raising C$4 Million in Bought-Deal Offering of Share Uni..
MT
More news
News in other languages on CRONOS GROUP INC.
09:30aTRACKINSIGHT : Mauvaise performance pour le plus large ETF de valeurs liées au c..
09:20aIRW-PRESS : EnWave Corporation: EnWave gibt das -2-
09:20aIRW-PRESS : EnWave Corporation: EnWave gibt das erste Quartal 2021 bekannt Konso..
02/25IRW-PRESS : Centurion Minerals Ltd.: Centurion -2-
02/25IRW-PRESS : Centurion Minerals Ltd.: Centurion schließt endgültige Vereinbarung ..
More news
Analyst Recommendations on CRONOS GROUP INC.
More recommendations
Chart CRONOS GROUP INC.
Duration : Period :
Cronos Group Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends CRONOS GROUP INC.
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 12
Average target price 7,92 CAD
Last Close Price 13,58 CAD
Spread / Highest target -19,0%
Spread / Average Target -41,7%
Spread / Lowest Target -63,2%
EPS Revisions
Managers and Directors
NameTitle
Kurt T. Schmidt President & Chief Executive Officer
Jerry F. Barbato Chief Financial Officer
Michael Ryan Gorenstein Executive Chairman
Jason Marc Adler Independent Director
James D. Rudyk Lead Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
CRONOS GROUP INC.53.62%3 909
CANOPY GROWTH CORPORATION33.52%12 681
CURALEAF HOLDINGS, INC.31.23%10 934
APHRIA INC.160.91%5 907
BEIJING TONGRENTANG CO., LTD12.47%5 711
DONG-E-E-JIAO CO.,LTD.-4.29%3 696